NCT02948972

Brief Summary

The ENDOFERT Study is an open, multicenter, randomized, parallel-group, controlled trial. This study includes patients presenting colorectal DIE and infertility. Patients will be randomized in two parallel-groups; one group underwent complete surgery of colorectal DIE prior to ART and the other group underwent ART alone (ratio 1:1)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2016

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 31, 2016

Completed
17 days until next milestone

Study Start

First participant enrolled

November 17, 2016

Completed
9.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

9.5 years

First QC Date

October 4, 2016

Last Update Submit

April 17, 2026

Conditions

Keywords

deep infiltrating endometriosisendometriosis surgeryIn vitro fertilization

Outcome Measures

Primary Outcomes (1)

  • Clinical pregnancy after 2 IVF cycles

    Clinical pregnancy is defined as pregnancy at 6 weeks of gestation with ultrasound echographic confirmation. An IVF cycle is defined as the transfer of all the embryos created via IVF after 1 oocytes puncture until a pregnancy confirmation or until the failure of the last embryo transfer. 2 embryos are transferred for each transfer steps. The length of one cycle depend on the number of embryo transfer steps. It is usually between 2 and 9 months.

    At the end of the 2nd IVF cycle (therefore at 6 weeks after each embryo transfer)

Secondary Outcomes (11)

  • predictive factors

    At the end of the 2nd IVF cycle

  • Clinical pregnancy rate after 1st IVF cycle

    At the end of the 1st IVF cycle (therefore at 6 weeks after each embryo transfer)

  • Clinical pregnancy rate per embryo transferred

    At the end of the 2nd IVF cycle (therefore at 6 weeks after each embryo transfer)

  • The IVF complication

    24 months after surgery or inclusion in "IVF without surgery" group

  • perioperative complications

    24 months after surgery

  • +6 more secondary outcomes

Study Arms (2)

complete surgery

EXPERIMENTAL

Prior surgery 3 months before IVF followup 1, 6 12 and 24 month after surgery

Procedure: complete surgeryProcedure: In vitro fertilization without surgery

In vitro fertilization without surgery

ACTIVE COMPARATOR

IVF without endometriosis surgery follow up 6, 12 and 24 month after inclusion.

Procedure: In vitro fertilization without surgery

Interventions

complete surgery of colorectal deep infiltrating endometriosis

complete surgery

IVF without endometriosis surgery

In vitro fertilization without surgerycomplete surgery

Eligibility Criteria

Age18 Years - 38 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Primary and secondary infertility
  • Indication for IVF
  • Persistent pain related to endometriosis with analgesic medical treatment failure
  • Persistent pain including at least one of the following digestive symptoms related to endometriosis: Dyschesia / Sub-occlusive syndrome / Rectal bleeding / Painful defecation
  • Colorectal deep infiltrating endometriosis : Whatever lesion size / With at least rectal serosal involvement / Confirmed by MRI and 1 different investigation: vaginal ultrasound echography or coloscopic CT scan or rectal endoscope ultrasound
  • Eligible for DIE surgery

You may not qualify if:

  • Contraindication to pregnancy or to IVF
  • Viral risk
  • Previous IVF cycle(s)
  • Previous colorectal surgery
  • Need of myomectomy during surgery
  • The use of oocytes donor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

CHU

Clermont-Ferrand, France

RECRUITING

Hôpital Jeanne de Flandres, CHRU

Lille, France

RECRUITING

AP-HP, Hôpital Tenon

Paris, France

RECRUITING

CHU

Poissy, France

RECRUITING

CHU

Rouen, France

RECRUITING

Related Publications (1)

  • Ledu N, Rubod C, Piessen G, Roman H, Collinet P. Management of deep infiltrating endometriosis of the rectum: Is a systematic temporary stoma relevant? J Gynecol Obstet Hum Reprod. 2018 Jan;47(1):1-7. doi: 10.1016/j.jogoh.2017.10.005. Epub 2017 Oct 31.

MeSH Terms

Conditions

EndometriosisInfertility

Interventions

Fertilization in VitroSurgical Procedures, Operative

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Reproductive Techniques, AssistedReproductive TechniquesTherapeuticsInvestigative Techniques

Study Officials

  • Pierre Collinet, MD, PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pierre Collinet, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2016

First Posted

October 31, 2016

Study Start

November 17, 2016

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations